The Wayback Machine - https://web.archive.org/web/20120523060449/http://en.wikipedia.org/wiki/5-MeO-NBpBrT

5-MeO-NBpBrT

From Wikipedia, the free encyclopedia
Jump to: navigation, search
5-MeO-NBpBrT
Systematic (IUPAC) name
N-(4-Bromobenzyl)-2-(5-methoxy-1H-indol-3-yl)ethanamine
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
ATC code  ?
PubChem CID 5124753
ChemSpider 4299315 YesY
ChEMBL CHEMBL57427 YesY
Chemical data
Formula C18H19BrN2O 
Mol. mass 359.260 g/mol
SMILES eMolecules & PubChem
 YesY (what is this?)  (verify)

5-MeO-NBpBrT (5-Methoxy-N-(4-bromobenzyl)tryptamine) is a drug which acts as an antagonist for the 5-HT2A receptor,[1] with a claimed 100x selectivity over the closely related 5-HT2C receptor.[2] While N-benzyl substitution of psychedelic phenethylamines often results in potent 5-HT2A agonists, N-benzyl tryptamines show much lower efficacy and are either very weak partial agonists or antagonists at 5-HT2A.[3][4]

[edit] See also

[edit] References

  1. ^ Niels Jensen. Tryptamines as Ligands and Modulators of the Serotonin 5-HT2A Receptor and the Isolation of Aeruginascin from the Hallucinogenic Mushroom Inocybe aeruginascens. PhD dissertation, Georg-August-Universität zu Göttingen, 2004.
  2. ^ Glennon RA, Dukat M, el-Bermawy M, Law H, De los Angeles J, Teitler M, King A, Herrick-Davis K. Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines. Journal of Medicinal Chemistry. 1994 Jun 24;37(13):1929-35. PMID 8027974
  3. ^ Maria Silva PhD. Theoretical study of the interaction of agonists with the 5-HT2A receptor. Universität Regensburg, 2009.
  4. ^ Silva ME, Heim R, Strasser A, Elz S, Dove S (January 2011). "Theoretical studies on the interaction of partial agonists with the 5-HT(2A) receptor". Journal of Computer-aided Molecular Design 25 (1): 51–66. doi:10.1007/s10822-010-9400-2. PMID 21088982. 


Personal tools
Namespaces

Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Morty Proxy This is a proxified and sanitized view of the page, visit original site.